Stock Traders Buy High Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw unusually large options trading on Wednesday. Stock traders purchased 1,885 put options on the stock. This represents an increase of approximately 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Stock Performance

NASDAQ:EVLO opened at $0.06 on Thursday. Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $13.93. The stock has a fifty day moving average price of $0.03 and a two-hundred day moving average price of $0.05. The stock has a market capitalization of $1.14 million, a price-to-earnings ratio of 0.00 and a beta of 1.75.

Hedge Funds Weigh In On Evelo Biosciences

An institutional investor recently raised its position in Evelo Biosciences stock. FMR LLC boosted its stake in shares of Evelo Biosciences, Inc. (NASDAQ:EVLO) by 1,835.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,446,390 shares of the company’s stock after buying an additional 2,319,965 shares during the quarter. FMR LLC owned 12.92% of Evelo Biosciences worth $9,590,000 as of its most recent filing with the Securities and Exchange Commission. 0.31% of the stock is currently owned by institutional investors.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.